Mucosal immunosenescence: new developments and vaccines to control infectious diseases.
about
Enterotypes of the human gut microbiomeOral supplementation with Lactobacillus delbrueckii subsp. bulgaricus 8481 enhances systemic immunity in elderly subjectsNovel vaccine development strategies for inducing mucosal immunityMucosal Immunosenescence in the Gastrointestinal Tract: A Mini-ReviewA molecular mucosal adjuvant to enhance immunity against pneumococcal infection in the elderlyConsumption of Bifidobacterium lactis Bi-07 by healthy elderly adults enhances phagocytic activity of monocytes and granulocytesInside the mucosal immune systemBarrier immune effectors are maintained during transition from nurse to forager in the honey beeVaccination strategies to promote mucosal antibody responses.Compositional dynamics of the human intestinal microbiota with aging: implications for health.Probiotic cheese containing Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFM® modifies subpopulations of fecal lactobacilli and Clostridium difficile in the elderlyAging impairs murine B cell differentiation and function in primary and secondary lymphoid tissuesThe role of nutrition in enhancing immunity in agingCrucial roles of B7-H1 and B7-DC expressed on mesenteric lymph node dendritic cells in the generation of antigen-specific CD4+Foxp3+ regulatory T cells in the establishment of oral toleranceImpaired innate mucosal immunity in aged mice permits prolonged Streptococcus pneumoniae colonization.The interaction between gut microbiota and age-related changes in immune function and inflammation.Mucosal adjuvants for vaccines to control upper respiratory infections in the elderly.Severe acute respiratory syndrome-coronavirus infection in aged nonhuman primates is associated with modulated pulmonary and systemic immune responses.Archaeal lipid mucosal vaccine adjuvant and delivery system.Impact of aging on dendritic cell functions in humans.Aging affects human B cell responses.Clostridium difficile infection in patients with HIV/AIDS.The influence of ageing on the development and management of rheumatoid arthritis.IBD across the age spectrum: is it the same disease?Inflammatory bowel disease and the elderly: a review.Management of allergic disease in the elderly: key considerations, recommendations and emerging therapies.Compartmentalization of immunosenescence: a deeper look at the mucosa.Pneumococcal Capsular Polysaccharide Immunity in the Elderly.Ageing and ocular surface immunity.Rejuvenation of mucosal immunosenescence by adipose tissue-derived mesenchymal stem cells.Vaccination against Salmonella Infection: the Mucosal Way.Brief communication: chronic undernutrition is associated with higher mucosal antibody levels among Ariaal infants of northern Kenya.Neuroimmune Modulation of Gut Function.Decreased Taxon-Specific IgA Response in Relation to the Changes of Gut Microbiota Composition in the Elderly.Is there any room for therapeutic vaccination against the HIV-1/AIDS?Aging Effects on Humoral Immune Responses in Chronic Periodontitis.Effect of dietary addition of seaweed and licorice on the immune performance of pigs.
P2860
Q24489818-696D0EDF-EEFC-44AE-B7D0-FE332B49C04EQ24602383-9BAE6C87-0162-479E-8CBD-8A1A7F107DEBQ24607533-15A40F75-3C16-4C51-8430-B8720D0DBAC8Q27015768-C63C7940-F95B-48D1-904B-2FACAFC06D00Q28084760-A01C3F12-15AE-410E-A8DA-9D2EDBE9550EQ34125988-981FC602-1A77-4013-99BF-9E41A5F02851Q34437474-F9121528-E3DE-4935-9E46-38BE82024198Q34548415-BFB3BC3A-B0B7-4FF9-8CF2-DAE80596D15FQ34610624-2EF4761A-89BE-4B54-A857-CC1A6A55C178Q35412870-3CF8FC17-14A5-4603-93E6-619EF5E7B983Q35678186-1553B6A1-3F12-4B46-AF1A-F0F06DA545F6Q35806803-E19D99EB-DED3-4E22-8D11-23AB268EF7BFQ35874114-641EA2AA-3929-4CE1-8A82-ED8D04D9E55BQ36012157-3C476459-C93D-4733-8D43-3630B8BDB396Q37336016-05AC09DD-5046-47D7-B0B4-7EF70E410B8EQ37359975-1E8A7F71-D465-4AD6-87AF-5FE29A849F2FQ37706979-D57C3505-2192-4381-B8E7-23D398C31823Q37723794-745BA7B1-C6F0-4DA6-93C8-CEB3E6517923Q37724863-6D7E12CA-0906-45EC-A0ED-5A6C26B717C1Q37771485-E36CFFD4-07C8-4F6E-BCB4-EF333EB8F3B3Q37841206-C53E7C80-D376-488E-AF23-C7B2E0517E72Q38105281-3DA93DF7-4EFA-4914-863C-DA300FA55667Q38115131-7D2C6CD4-E3EE-4371-A020-B5D0E992D053Q38171927-A69C5165-DDBD-4D6A-9E0C-379641070AB8Q38419578-A40A0B62-EF5A-437D-AD57-EE18B6ACFEF6Q38611671-49A51082-9EE9-4866-BA8D-74D009A90FEAQ38675016-860A73A3-9C8A-46FA-9D2A-63BFDE94E1CEQ38861144-EF9A0135-35CA-4491-95E1-548CE1CBB188Q38886086-0DEB009D-9E38-4A46-834B-EF8DAD2B91C5Q39229257-4CBF7363-0F3D-47B7-9C75-3F2C68DBF4B1Q39373957-8A229B2C-6AF2-4215-AB06-9E9BBFE5F876Q39595089-072CBE4B-68BB-45D4-BB95-D01075D778D4Q40431964-5422C91D-8C08-44D0-BFB5-491FA8E8EA42Q41684214-B5AF0C4A-F1BA-4DF3-99F6-B995C844FC65Q46072177-3BC47900-8658-4E40-8150-4394F1A9454CQ51151389-1A689353-EDB8-4CB0-A847-C3D6E6DE265AQ54361311-DCAFDC08-7501-43D7-B399-823D7F554B94
P2860
Mucosal immunosenescence: new developments and vaccines to control infectious diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mucosal immunosenescence: new developments and vaccines to control infectious diseases.
@en
Mucosal immunosenescence: new developments and vaccines to control infectious diseases.
@nl
type
label
Mucosal immunosenescence: new developments and vaccines to control infectious diseases.
@en
Mucosal immunosenescence: new developments and vaccines to control infectious diseases.
@nl
prefLabel
Mucosal immunosenescence: new developments and vaccines to control infectious diseases.
@en
Mucosal immunosenescence: new developments and vaccines to control infectious diseases.
@nl
P356
P1433
P1476
Mucosal immunosenescence: new developments and vaccines to control infectious diseases.
@en
P2093
Hiroshi Kiyono
Kohtaro Fujihashi
P304
P356
10.1016/J.IT.2009.04.004
P577
2009-06-18T00:00:00Z